Susan Korenchuk
- Molecular Biology top 10%
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 10%
- Cancer Research top 10%
- Hematology top 5%
- Co-authors
- Kenneth J. PientaS WhitneyJ E LehrJill A. MacoskaLisa L. McLeanDin L. LinR L VessellaNeil R. Mucci
- Topics
- Ubiquitin and proteasome pathways (5 papers)Protein Degradation and Inhibitors (5 papers)Prostate Cancer Treatment and Research (4 papers)
- Partner nations
- United StatesSouth KoreaNetherlands
In The Last Decade
Susan Korenchuk
18 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 81
- Molecular Biology 896
- Pulmonary and Respiratory Medicine 462
- Oncology 348
- Cancer Research 204
- Hematology 165
Countries citing papers authored by Susan Korenchuk
This map shows the geographic impact of Susan Korenchuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Korenchuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Korenchuk more than expected).
Fields of papers citing papers by Susan Korenchuk
This network shows the impact of papers produced by Susan Korenchuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Korenchuk. The network helps show where Susan Korenchuk may publish in the future.
Co-authorship network of co-authors of Susan Korenchuk
This figure shows the co-authorship network connecting the top 25 collaborators of Susan Korenchuk. A scholar is included among the top collaborators of Susan Korenchuk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Korenchuk. Susan Korenchuk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 23 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 151 | |
| 5 | 136 | |
| 6 | 2 | |
| 7 | 17 | |
| 8 | 86 | |
| 9 | 62 | |
| 10 | Abstract #1740: Characterization of GSK1838705A, a small molecule inhibitor of the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase that delays growth of IGF-1R-dependent tumors and causes regression of ALK-dependent tumors in vivo | 2 |
| 11 | 138 | |
| 12 | 100 | |
| 13 | Mechanisms of in vitro acquired resistance to vorinostat (suberoylanilide hydroxamic acid, SAHA) | 3 |
| 14 | 146 | |
| 15 | Establishment and characterization of a new human prostatic cancer cell line: DuCaP. | 38 |
| 16 | VCaP, a cell-based model system of human prostate cancer. | 250 |
| 17 | 32 | |
| 18 | Rapid ("warm") autopsy study for procurement of metastatic prostate cancer. | 172 |
About Susan Korenchuk
Susan Korenchuk is a scholar working on Molecular Biology, Neurology and Endocrinology, Diabetes and Metabolism, having authored 18 papers that have together received 1.4k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (5 papers), Protein Degradation and Inhibitors (5 papers) and Prostate Cancer Treatment and Research (4 papers). The work is most often cited by research in Hematology (165 citations), Pulmonary and Respiratory Medicine (462 citations) and Cancer Research (204 citations). Susan Korenchuk has collaborated with scholars based in United States, South Korea and Netherlands. Frequent co-authors include Kenneth J. Pienta, S Whitney, J E Lehr, Jill A. Macoska, Lisa L. McLean, Din L. Lin, R L Vessella, Neil R. Mucci, David C. Smith and Mark A. Rubin. Their work appears in journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.